Q&A: Iksuda Therapeutics: Leading the way on helping to advance care for ovarian and lung cancer patients

By |2022-02-18T10:20:49+00:00October 11th, 2019|Archive|

We talk to David Simpson, CEO at Iksuda Therapeutics about what they do, how

Comments Off on Q&A: Iksuda Therapeutics: Leading the way on helping to advance care for ovarian and lung cancer patients
Go to Top